Bench to Bedside Pt. 2: Financial Toxicity in Patients With Hematologic Malignancies
Hematopoiesis: An ASH Trainee Council Production
English - December 02, 2022 19:57 - 19 minutes - 16.5 MB - ★★★★ - 10 ratingsNatural Sciences Science Health & Fitness Medicine hematopoiesis hematology hematologist medicine blood trainees fellows education career physician Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: The Era of Gene Therapy in Clinical Hematology, From Bench to Bedside!
In the second episode of this Hematopoiesis Bench to Bedside series, Dr. Manuel Espinoza-Gutarra has conversations with Dr. Aaron Mitchell, Dr. Yousuf Zafar (@yzafar), Dr. Aju Mathew, and Dr. Nandita Khera (@khera_nandita), experts in the field of financial toxicity in cancer patients, who offer different perspectives regarding the impact of the financial costs of modern anticancer treatment puts on patients, how should we adequately measure it and how to tackle it.
Music: “Somebody New” RYYZN (www.toneden.io/ryyzn/post/somebody-new-copyright-free). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/.